Tomas Hode, PhD, who serves as the Co-Founder, CIO, and President at Immunophotonics, Inc. is eager to attend the AngioDynamics...

Immunophotonics to be showcased as the Member Highlight for March by The Missouri Biotechnology Association (MOBIO), both on their homepage...

Immunophotonics Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President have announced a partnership that will combine use of...

Immunophotonics, Inc. is grateful to NCI (National Cancer Institute) SBIR Investor Initiatives Team for providing us the opportunity to showcase...

Congratulations to Professor Wei Chen and his lab at the University of Oklahoma, along with contributors Lu Alleruzzo, Samuel S.K....

St. Louis cancer drug startup Immunophotonics Inc. will pursue expansion of its lead drug candidate through a partnership with the...

Tomas Hode, PhD, Co-Founder, CIO, and President at Immunophotonics, Inc. will be attending the SIO Annual Scientific Meeting January 26...

Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) are looking forward to attending Spectrum Conference, January...

Our networking is well underway with investors and potential strategic partners for the JPM 2024.  Attending the annual summit Lu...

Immunophotonics Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President have announced a research collaboration with Johnson & Johnson...